Description: With deep expertise in chemistry and structure-based drug discovery, Nuvalent is creating precisely targeted therapies for patients with cancer.
cancer (3381) clinical trial (179) cancer therapy (66) alk (26) alkove-1 (6) arros-1 (6) cambridge biotech (6) cambridge biopharma (6) clinical stage (6) cancer trial (6)
We partner with physician-scientists to identify patient needs and the limitations of existing therapies.
We are passionate about using our expertise to address the needs of patients with cancer.
A Phase 1/2 study of NVL-520 in patients with advanced ROS1-positive NSCLC and other solid tumors.